Will our cardiomyopathy patients accept gene therapy?

Novel techniques such as gene therapy are becoming available in an attempt to cure inherited diseases. Before these new therapies can be offered to patients, we need to be aware of potential reservations or objections, not only from patients and their surroundings but also from the public. In additi...

Descripción completa

Detalles Bibliográficos
Autores principales: Doevendans, P. A., Kupatt, C., Giacca, M., Glijnis, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2022
Materias:
Point of View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270505/
https://www.ncbi.nlm.nih.gov/pubmed/35235143
http://dx.doi.org/10.1007/s12471-022-01665-z
Descripción
Sumario:Novel techniques such as gene therapy are becoming available in an attempt to cure inherited diseases. Before these new therapies can be offered to patients, we need to be aware of potential reservations or objections, not only from patients and their surroundings but also from the public. In addition, legal issues and costs need attention before curative gene therapy can be applied in the clinic. As this therapeutic approach is closer to becoming a reality, now is the right time to start the debate.

Ejemplares similares